|
MTMR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.43170000486282E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.55710000027921E-09 |
| Normal-vs-Stage2 |
1.574240E-04 |
| Normal-vs-Stage3 |
1.67348999999817E-05 |
| Normal-vs-Stage4 |
1.09749986876295E-10 |
| Stage1-vs-Stage2 |
7.226400E-01 |
| Stage1-vs-Stage3 |
3.215800E-01 |
| Stage1-vs-Stage4 |
4.14960000000297E-05 |
| Stage2-vs-Stage3 |
2.907600E-01 |
| Stage2-vs-Stage4 |
2.995200E-04 |
| Stage3-vs-Stage4 |
1.427570E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44710002156512E-09 |
| Normal-vs-AfricanAmerican |
3.4834999995681E-07 |
| Normal-vs-Asian |
9.78080000000325E-05 |
| Caucasian-vs-AfricanAmerican |
9.101600E-01 |
| Caucasian-vs-Asian |
4.184400E-01 |
| AfricanAmerican-vs-Asian |
3.470200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.306100169302E-10 |
| Normal-vs-Female |
2.041700E-03 |
| Male-vs-Female |
4.839800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.92069999980372E-07 |
| Normal-vs-Extreme_Weight |
1.35139999191125E-09 |
| Normal-vs-Obese |
3.65840000000617E-05 |
| Normal-vs-Extreme_Obese |
9.77330000000443E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.456400E-01 |
| Normal_Weight-vs-Obese |
1.334020E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.920000E-01 |
| Extreme_Weight-vs-Obese |
6.002300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.496800E-01 |
| Obese-vs-Extreme_Obese |
4.163000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.035500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.19180000005093E-06 |
| Normal-vs-Age(61-80Yrs) |
7.55829954179887E-10 |
| Normal-vs-Age(81-100Yrs) |
1.1099999996933E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.397800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.552200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.182300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.615700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.212200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.480760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.07139999994521E-07 |
| Normal-VS-Type2 PRCC |
4.33542091116124E-13 |
| Normal-VS-KIRP CIMP |
8.578500E-02 |
| Normal-VS-Unclassified PRCC |
3.220700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.69111999999139E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.998000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.445800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.613000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.860400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.796000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39142039504259E-12 |
| Normal-vs-N1 |
3.985600E-04 |
| Normal-vs-N2 |
4.13420000000553E-05 |
| N0-vs-N1 |
6.098400E-01 |
| N0-vs-N2 |
3.322000E-01 |
| N1-vs-N2 |
1.154250E-01 |
|
|
